Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon May 05, 2021 6:18pm
54 Views
Post# 33137439

RE:RE:why did they writedown ivigfor 150 millio when it was close

RE:RE:why did they writedown ivigfor 150 millio when it was close H Grognon

What do you know in PPPS technology ? The IVIG produce was the purest in multi Billions $$$ Canadian market. The biggest per capita and the most growing one.

Sorry but you talk like a looser. Ther problem with IVIG is purity. Many users have to change because of adverse reactions. Quality, purity are the essence and the way of succes 
<< Previous
Bullboard Posts
Next >>